Marty Nazzaro
Geschäftsführer bei Inflammasome Therapeutics, Inc.
Profil
Marty Nazzaro is currently the Vice President-Operations at Inflammasome Therapeutics, Inc. He previously worked as a Manufacturing Director at Control Delivery Systems, Inc. and as an Operations Director at EyePoint Pharmaceuticals, Inc. from 2006 to 2009.
He obtained his undergraduate degree from Suffolk University.
Aktive Positionen von Marty Nazzaro
Unternehmen | Position | Beginn |
---|---|---|
Inflammasome Therapeutics, Inc.
Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Geschäftsführer | 01.03.2020 |
Ehemalige bekannte Positionen von Marty Nazzaro
Unternehmen | Position | Ende |
---|---|---|
Control Delivery Systems, Inc.
Control Delivery Systems, Inc. Medical SpecialtiesHealth Technology Control Delivery Systems Inc. designs, develops and manufactures drug delivery products. The products are designed to deliver precise quantities of drugs to difficult-to-treat areas of the body. The company was founded in 1991 and is headquartered in Watertown, MA. | Corporate Officer/Principal | - |
EYEPOINT PHARMACEUTICALS, INC. | Geschäftsführer | - |
Ausbildung von Marty Nazzaro
Suffolk University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Control Delivery Systems, Inc.
Control Delivery Systems, Inc. Medical SpecialtiesHealth Technology Control Delivery Systems Inc. designs, develops and manufactures drug delivery products. The products are designed to deliver precise quantities of drugs to difficult-to-treat areas of the body. The company was founded in 1991 and is headquartered in Watertown, MA. | Health Technology |
Inflammasome Therapeutics, Inc.
Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Health Technology |